Key points are not available for this paper at this time.
S5. MEK inhibitors block OSM-driven conversion to a CD44HI/mesenchymal state.
Polak et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: